Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2025-12-17 @ 2:44 AM
Study NCT ID:
NCT04668300
Status:
None
Last Update Posted:
2025-10-09 00:00:00
First Post:
2020-08-18 00:00:00
Brief Title:
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
Sponsor:
MD Anderson Cancer Center
Organization:
M.D. Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-18 00:00:00
First Submit QC Date:
December 9 2020
Study First Post Date:
2020-12-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-07 00:00:00
Last Update Post Date:
2025-10-09 00:00:00
Last Update Post Date Type:
ESTIMATED